INTRODUCTION
There is data to suggest that prolactin (PRL) plays an important role in the regulation of reproductive cyclicity, lactational infertility and hyperprolactinemia-associated disfunctions of the gonads. In particular, PRL receptors have been demonstrated in granulosa and luteal cells in the pig (Dusza and Tilton, 1990) and in ovarian follicles in the hamster (Roy et al, 1987) but not in bovine ovarian follicles (Bevers et al, 1988) . It Rajkumar, 1985; Tsafriri, 1988; Dusza and Tilton, 1990) . However, information on the direct action of PRL is limited almost entirely to an influence on ovarian steroidogenesis and some of the data is contradictory. In particular, an artifical increase in blood PRL concentration failed to change steroid levels in bovine (Bevers et al, 1988) , ovine and porcine (Dusza, 1989; Dusza and Tilton, 1990) plasma. On the other hand, PRL inhibited steroid production by rat ovaries in vivo (Kalison et al, 1985, Adashi and Resnik, 1987) , by perfused human ovaries (Demura ef al, 1982) , by human (Sato et al, 1985) , pig and rat (Adashi and Resnik, 1987; Gitay-Goren et al, 1989a,b) granulosa cells, and by rat thecainterstitial cells (Magoffin and Erikson, 1982; McNeilly, 1984) . Aromatase activity in isolated hen ovarian follicles (Zadworny et al, 1989) and rat granulosa cells (Dorrington and Gore-Langton, 1982; Wang and Chan, 1982; Gitay-Goren et al, 1989 a,b; Krasnow et al, 1990) was also inhibited. In other reports, PRL stimulated progesterone production by rat (Wang and Chan, 1982) and porcine (Einspanier et al, 1986 ) granulosa cell cultures.
PRL stimulated LH receptor formation (Murphy and Rajkumar, 1985; Adashi and Resnik, 1987) , lipoprotein uptake (Murphy and Rajkumar, 1985; Rajkumar et al, 1988) and progesterone (Grinwich et al, 1983; and progesterone (Grinwich et al, 1983; Murphy and Rajkumar, 1985) but not androgen (Gregoraszczuk, 1985) release from porcine luteal cells. PRL also activated lipoprotein utilization and progesterone production by porcine granulosa cells luteinized in culture (Chedreese et al, 1988) . In rat luteal cells, PRL stimulated progesterone, testosterone and estradiol release (Kalison et al, 1985; Menon et al, 1985; Rajkumar, 1985, Gitay-Goren et al, 1989a) . Enhanced progesterone output was observed after PRL treatment in human corpus luteum slices in culture (Hunter, 1989) . In other in vitro experiments PRL either had no effect on porcine luteal cell progesterone production (Gregoraszczuk, 1985) or it was inhibitory (Grazul, 1985; Einspanier et al, 1986 (Guraya, 1985; Hansel and Dowd, 1986; Richards and Hedin, 1988; Tsafriri, 1988; Wathes, 1989) . There is little information concerning PRL's influence on the non-steroidal ovarian substances. GitayGoren et al (1989a,b) reported that PRL inhibited cAMP release from rat granulosa cells in culture, in contrast to its effect on mammary tissue (Rillema etal, 1988 (fig 1 ) . PRL doses of 10 and 1 000 pmol/ml signifi-icantly (p < 0.001 ) increased cyclic nucleotide CAMP accumulation (fig 2) . Higher PRL doses produced a lower level of stimulation and the effect at 10 000 pmol/ml was not significant. Low PRL doses (1 or 10 0 pmovml) decreased oxytocin release (p < 0.001 and p < 0.05 respectively) whilst doses of 1 000 pmol/ml and above were highly stimulatory (p < 0.01 ) (fig 3) .
DISCUSSION
The results presented in table I are consistent with available data (Guraya, 1985; Wathes, 1989) Gitay-Goren et al, 1989ab; Krasnow et al, 1990) , particularly in hen (Zadworny et al, 1989) and human (Demura et al, 1982) ovarian follicular cells. It has been shown (Ledwitz-Rigby, 1987; Einspanier et al, 1991) that, as in other mammals (Guraya, 1985) , the luteinization of porcine follicles in vivo and in vitro is associated with a decrease in estradiol release and with the subsequent stimulation of progesterone output. Murphy and Rajkumar, 1985; Dusza and Tilton, 1990 ) that during corpus luteum development and lactation a high blood PRL level can inhibit follicular development, steroidogenesis and ovulation and maintain corpus luteum function.
These effects may be mediated by cAMP-dependent intracellular mechanisms.
In rat follicular cells, PRL-induced inhibition of progesterone release was accompanied by stimulation, and PRL-activated progesterone secretion in rat luteocytes by reduction of cAMP accumulation in the culture medium (Gitay-Goren etal, 1989a,b) . In the granulosa cells, PRL prevented the steroidogenic effects of forskolin (a stimulator of cAMP production) (Krasnow etal, 1990 ), but not of 3-isobutyl-1-methylxanthine (a blocker of phosphodiesterase) (Gitay-Goren et al, 1989b (Rillema et al, 1988 (Wathes, 1989; Wathes et al, 1992) . It cannot be excluded that the PRL-stimulated oxytocin release is due to the stimulation of cAMP production since the cAMP analogue dbcAMP or 3-isobutyl-1-methylxanthine can stimulate oxytocin release by bovine granulosa cells in culture (Wathes, 1989) . Thus the present observations, together with published reports, suggest the hypothesis that the first step in the action of PRL on ovarian cells includes the stimulation of cAMP formation and/or the inhibition of cAMP catabolism. The second step may be a cAMP-induced luteinization of the cell including specific changes in steroidogenesis (inhibition of estrogen and activation of progesterone secretion) and the stimulation of oxytocin release. On the other hand, a feedback effect of oxytocin and steroid hormones (Sirotkin and Nitray, 1993) on cAMP release, as well as a reciprocal influence of steroids on oxytocin (Wathes, 1989; Sirotkin and Nitray, 1992) can also occur.
The fine interrelationships between ovarian cyclic nucleotides, steroid and nonapeptide hormones require further investigation, but these data suggest that PRL influences all these 3 classes of biologically active substances, playing an important role in the regulation of ovarian function.
